Vir Biotechnology, Inc. (NASDAQ:VIR) Q4 2024 Earnings Call Transcript February 26, 2025
Vir Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.76, expectations were $-0.85.
Operator: Hello. Welcome to Vir Biotechnology’s Fourth Quarter and Full Year 2024 Financial Results and Business Update Call. As a reminder, this conference call is being recorded. At this time, all participants are in a listen-only mode. After the speakers presentation, there will be a...
